drugset
drugset / Trial / NCT01753791

Study To Evaluate Safety, Tolerability, And Pharmacokinetics Of PF-06473871 In Normal Healthy Adults

NCT01753791 ↗

Phase 1 Completed 32 enrolled Pfizer
RandomizedSingle-groupDouble-blindBasic science

Summary

The purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics of PF-06473871 in normal healthy adults.

Timeline

Start
2012-11
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-06473871 Unknown 80 mg —
Subject PF-06473871 Unknown 160 mg —
Subject PF-06473871 Unknown 320 mg —
Subject PF-06473871 Unknown 480 mg —

Indications

No indication recorded.